Table 5 Type of anti-osteoporosis drugs used in the BMD <70 % of YAM and BMD ≥70 % of YAM groups
From: Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
|  | BMD <70 % of YAM | BMD ≥70 % of YAM | p value |
|---|---|---|---|
Bisphosphonate | 30 | 54 | 0.087 |
PTH | 4 | 1 | 0.008* |
Others | 10 | 16 | 0.351 |